Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01659333
Other study ID # 2010/10
Secondary ID
Status Completed
Phase N/A
First received August 4, 2012
Last updated August 4, 2012
Start date January 2011
Est. completion date February 2012

Study information

Verified date August 2012
Source TC Erciyes University
Contact n/a
Is FDA regulated No
Health authority Turkey: Ethics Committee
Study type Observational

Clinical Trial Summary

Dry weight (DW) assessment is essential for the efficient treatment of peritoneal dialysis (PD) patients but so far objective methods for DW assessment have not been established for daily clinical practice. Our aim was to evaluate hydration state in PD patients by using a body composition monitor (BCM) and calf bioimpedance (c-BI) and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) levels and to compare both methods with arterial stiffness.


Description:

We evaluated 60 patients using a new BCM device that implies a validated body composition model. This method allows correct quantification of extracellular fluid overload or deficiency (normal limits:-1.1 to +1.1L). Patients were assigned to normo and hypervolemic groups according to BCM results. Also, normalized calf resistivity (nRho) was calculated from resistance at 5 Khz using c-BI and the levels of NT-proBNP were measured in all study patients. The analyses of arterial stiffness were performed by using the pulse wave velocity (PWV) technique on the patients. All patients underwent conventional echocardiography and their left ventricular diastolic functions were evaluated.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date February 2012
Est. primary completion date January 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Peritoneal dialysis patients

- All participants over 18 years of age

Exclusion Criteria:

- Patients with valvular heart disease

- Patients with coronary artery disease

- Patients with cardiomyopathy

- Patients with ESRD who underwent hemodialysis

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms

  • Disorders Associated With Peritoneal Dialysis

Locations

Country Name City State
Turkey Erciyes University Nephrology Department Kayseri

Sponsors (1)

Lead Sponsor Collaborator
TC Erciyes University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Terminated of patients recruiting One year No
See also
  Status Clinical Trial Phase
Completed NCT01021878 - Study to Evaluate the Effects Icodextrin Versus Dianeal on Insulin Resistance in Nondiabetic Automated Peritoneal Dialysis Patients Phase 4
Completed NCT01315314 - Effect of Glucose Degradation Products (GDP) on Endothelial Dysfunction Phase 4
Recruiting NCT02646436 - Peritoneal Dialysis as an Option of Unplanned Initiation of Chronic Dialysis N/A
Completed NCT01581996 - Fosrenol and Phosphorus Balance - Lanthanum Carbonate N/A
Completed NCT01575652 - Effects of Aceis on Peritoneal Protein Loss and Solute Transport in pd Patients Phase 4
Recruiting NCT02393261 - A Controlled and Multi-Center Study of 2500ml Huaren Peritoneal Dialysate N/A
Recruiting NCT02388945 - A Study of Domestic Automated Peritoneal Dialysis Machine N/A
Completed NCT02338128 - The Cardiovascular Protective Effects of Febuxostat in Peritoneal Dialysis Patients
Recruiting NCT02989298 - Peritoneal Dialysis Registration System (PERSIST)